ClinicalTrials.gg
Enrolling by invitationNCT07913438Updated Nov 3, 2026

Development and Implementation of a Breastfeeding Program for Post-Cesarean Section Women Based on the 5A Nursing Model

An interventional study of Based on the 5A nursing intervention plan and Implement routine care in Breastfeeding Rates, sponsored by The Third Xiangya Hospital of Central South University. Enrolling by invitation at 1 site in China. Open to female participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-11-03.

Sponsored by The Third Xiangya Hospital of Central South University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Mar 2026, registered Aug 2026).
Updated Nov 3, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Non-randomized
Ages
18 Years to 50 Years
Sex
Female
01

Study summary

Develop and apply a breastfeeding program for postoperative mothers of cesarean section based on the 5A nursing model, and evaluate its impact on the mothers' mastery of breastfeeding knowledge, self-efficacy, breastfeeding rate, and psychological state.

02

Conditions studied

  • Breastfeeding Rates

Browse trials for

03

In context

Breast Feeding

1,081 studies on the registry are indexed under Breast Feeding; 217 are open to participants now.

This study's planned enrollment of 60 is below the median of 100 across 844 interventional studies indexed under Breast Feeding.

Browse Breast Feeding studies →

Lead sponsor

The Third Xiangya Hospital of Central South University is the lead sponsor of 99 studies on the registry; 52 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Normal mental state, capable of cooperating to complete the experiment;
  • Full-term singleton pregnancy;
  • Parturient who underwent cesarean section delivery.

Exclusion criteria

Exclusion Criteria:

  • Emergency cesarean section was performed during vaginal delivery;
  • The pregnant woman had severe pregnancy complications or infectious diseases and was unable to breastfeed;
  • The newborn was transferred to the neonatal department due to illness treatment;
  • The mother strongly refused breastfeeding of her own will.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
60 participants (estimated)

Study arms

  • Active comparator
    Usual Care group

    Implement routine care

    Behavioral: Implement routine care

  • Experimental
    Intervention group

    Behavioral: Based on the 5A nursing intervention plan

Interventions

  • BehavioralBased on the 5A nursing intervention plan

    Based on literature research and qualitative interviews, and through the Delphi expert consultation method, a set of intervention measures was ultimately formulated.

  • BehavioralImplement routine care

    Implement routine care

06

What researchers measure

Primary outcomes

  1. Exclusive breastfeeding rate

    Time frame: Three days after giving birth and 42 days after giving birth

07

Study locations

1 site
  • The Third Xiangya hospital
    Changsha, China
08

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Nov 3, 2026
Show all 1 update
  1. Nov 3, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07913438
Lead sponsor
The Third Xiangya Hospital of Central South University
Responsible party
Sponsor
First posted
Nov 3, 2026
Start date
Mar 11, 2026
Primary completion
Mar 11, 2027 (estimated)
Completion
Mar 11, 2027 (estimated)
Last update
Nov 3, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion